Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 4
2020 3
2021 6
2022 6
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Microsatellite Instability-High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles.
Manning-Geist BL, Liu YL, Devereaux KA, Paula ADC, Zhou QC, Ma W, Selenica P, Ceyhan-Birsoy O, Moukarzel LA, Hoang T, Gordhandas S, Rubinstein MM, Friedman CF, Aghajanian C, Abu-Rustum NR, Stadler ZK, Reis-Filho JS, Iasonos A, Zamarin D, Ellenson LH, Lakhman Y, Mandelker DL, Weigelt B. Manning-Geist BL, et al. Clin Cancer Res. 2022 Oct 3;28(19):4302-4311. doi: 10.1158/1078-0432.CCR-22-0713. Clin Cancer Res. 2022. PMID: 35849120 Free PMC article.
The highs and lows of serous ovarian cancer.
Grisham RN, Manning-Geist BL, Chui MH. Grisham RN, et al. Among authors: manning geist bl. Cancer. 2023 Sep 1;129(17):2613-2620. doi: 10.1002/cncr.34903. Epub 2023 Jun 27. Cancer. 2023. PMID: 37366225 Review.
Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary study.
Sia TY, Manning-Geist BL, Ehmann S, Lavery JA, Luardo C, Praiss A, Iasonos A, Sonoda Y, Grisham RN, Liu YL, Broach V, Zivanovic O, Long Roche K, Gardner GJ, Chi DS. Sia TY, et al. Among authors: manning geist bl. Gynecol Oncol. 2023 Sep;176:69-75. doi: 10.1016/j.ygyno.2023.07.006. Epub 2023 Jul 14. Gynecol Oncol. 2023. PMID: 37454565
Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission.
Manning-Geist BL, Gnjatic S, Aghajanian C, Konner J, Kim SH, Sarasohn D, Soldan K, Tew WP, Sarlis NJ, Zamarin D, Kravetz S, Laface I, Rasalan-Ho T, Qi J, Wong P, Sabbatini PJ, O'Cearbhaill RE. Manning-Geist BL, et al. Cancers (Basel). 2023 Feb 25;15(5):1458. doi: 10.3390/cancers15051458. Cancers (Basel). 2023. PMID: 36900251 Free PMC article.
Quaternary and beyond cytoreduction: An updated and expanded analysis.
Manning-Geist BL, Chi DS, Long Roche K, Zivanovic O, Sonoda Y, Gardner GJ, O'Cearbhaill RE, Abu-Rustum NR, Leitao MM Jr. Manning-Geist BL, et al. Gynecol Oncol Rep. 2021 Aug 24;37:100851. doi: 10.1016/j.gore.2021.100851. eCollection 2021 Aug. Gynecol Oncol Rep. 2021. PMID: 34485661 Free PMC article.
Risk factors for financial toxicity in patients with gynecologic cancer.
Aviki EM, Manning-Geist BL, Sokolowski SS, Newman T, Blinder VS, Chino F, Doyle SM, Liebhaber A, Gordhandas SB, Brown CL, Broach V, Chi DS, Jewell EL, Leitao MM Jr, Long Roche K, Mueller JJ, Sonoda Y, Zivanovic O, Gardner GJ, Abu-Rustum NR. Aviki EM, et al. Among authors: manning geist bl. Am J Obstet Gynecol. 2022 Jun;226(6):817.e1-817.e9. doi: 10.1016/j.ajog.2021.12.012. Epub 2021 Dec 11. Am J Obstet Gynecol. 2022. PMID: 34902319 Free PMC article.
28 results